Previous Article | Next Article ![]()
Infect Immun, February 1998, p. 521-527, Vol. 66, No. 2
Bacteriology Division, U.S. Army Research
Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland
21702-5011
Received 28 July 1997/Returned for modification 2 September
1997/Accepted 17 November 1997
The V protein expressed by pathogenic Yersinia pestis
is an important virulence factor and protective immunogen. The
presence of linear B-cell epitopes in the V protein was investigated by using a series of 17 overlapping linear peptides. Groups of 10 mice were immunized intraperitoneally with 30 µg of each peptide on
days 0, 30, and 60. Although the V protein-specific antibody response
to the peptides varied, most of the peptides elicited high antibody
titers. The immunized mice were challenged subcutaneously with 60 50%
lethal doses (LD50) (1 LD50 = 1.9 CFU) of a
virulent Y. pestis strain, CO92. None of the
peptide-immunized mice survived challenge. The animals immunized with
the V protein were completely protected against challenge. The
immunogenicity of some of the V peptides was increased by conjugating
them to keyhole limpet hemocyanin. Only one peptide (encompassing amino
acids 1 to 30) conjugate demonstrated some protection; the others
were not protective. In additional experiments, V peptides that reacted
well with sera from mice surviving Y. pestis infection
were combined and used to immunize mice. Although the combined peptides
appeared to be very immunogenic, they were not protective. Therefore,
the protective B-lymphocyte epitope(s) in the V protein is most likely
to be conformational.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Analysis of the Yersinia pestis V
Protein for the Presence of Linear Antibody Epitopes

*
Corresponding author. Mailing address: Bacteriology
Division, U.S. Army Research Institute of Infectious Diseases, 1425 Porter St., Frederick, MD 21702-5011. Phone: (301) 619-4933. Fax: (301) 619-2152. E-mail:
ltc_george_anderson{at}detrick.army.mil.
Present address: SmithKline Beecham Biologicals, B1330 Rixensart,
Belgium.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|